Suppr超能文献

[德国S3指南 - 成年患者急性护理中的氧疗]

[German S3 Guideline - Oxygen Therapy in the Acute Care of Adult Patients].

作者信息

Gottlieb Jens, Capetian Philipp, Hamsen Uwe, Janssens Uwe, Karagiannidis Christian, Kluge Stefan, König Marco, Markewitz Andreas, Nothacker Monika, Roiter Sabrina, Unverzagt Susanne, Veit Wolfgang, Volk Thomas, Witt Christian, Wildenauer René, Worth Heinrich, Fühner Thomas

机构信息

Klinik für Pneumologie, Medizinische Hochschule Hannover.

Biomedical Research in End-stage and Obstructive Lung Disease Hannover (BREATH) im Deutschen Zentrum für Lungenforschung (DZL).

出版信息

Pneumologie. 2022 Mar;76(3):159-216. doi: 10.1055/a-1554-2625. Epub 2021 Sep 2.

Abstract

BACKGROUND

Oxygen (O) is a drug with specific biochemical and physiologic properties, a range of effective doses and may have side effects. In 2015, 14 % of over 55 000 hospital patients in the UK were using oxygen. 42 % of patients received this supplemental oxygen without a valid prescription. Healthcare professionals are frequently uncertain about the relevance of hypoxemia and have low awareness about the risks of hyperoxemia. Numerous randomized controlled trials about targets of oxygen therapy have been published in recent years. A national guideline is urgently needed.

METHODS

A S3-guideline was developed and published within the Program for National Disease Management Guidelines (AWMF) with participation of 10 medical associations. Literature search was performed until Feb 1st 2021 to answer 10 key questions. The Oxford Centre for Evidence-Based Medicine (CEBM) System ("The Oxford 2011 Levels of Evidence") was used to classify types of studies in terms of validity. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) was used and for assessing the quality of evidence and for grading guideline recommendation and a formal consensus-building process was performed.

RESULTS

The guideline includes 34 evidence-based recommendations about indications, prescription, monitoring and discontinuation of oxygen therapy in acute care. The main indication for O therapy is hypoxemia. In acute care both hypoxemia and hyperoxemia should be avoided. Hyperoxemia also seems to be associated with increased mortality, especially in patients with hypercapnia. The guideline provides recommended target oxygen saturation for acute medicine without differentiating between diagnoses. Target ranges for oxygen saturation are depending on ventilation status risk for hypercapnia. The guideline provides an overview of available oxygen delivery systems and includes recommendations for their selection based on patient safety and comfort.

CONCLUSION

This is the first national guideline on the use of oxygen in acute care. It addresses healthcare professionals using oxygen in acute out-of-hospital and in-hospital settings. The guideline will be valid for 3 years until June 30, 2024.

摘要

背景

氧气(O)是一种具有特定生化和生理特性的药物,有一系列有效剂量,且可能有副作用。2015年,英国超过55000名住院患者中有14%在使用氧气。42%的患者在没有有效处方的情况下接受了这种补充氧气。医疗保健专业人员常常不确定低氧血症的相关性,对高氧血症的风险认识不足。近年来发表了许多关于氧疗目标的随机对照试验。迫切需要一项国家指南。

方法

在10个医学协会的参与下,制定并在国家疾病管理指南计划(AWMF)内发布了一项S3指南。进行文献检索至2021年2月1日,以回答10个关键问题。采用牛津循证医学中心(CEBM)系统(“牛津2011证据级别”)根据有效性对研究类型进行分类。使用推荐分级、评估、制定和评价(GRADE)方法评估证据质量并对指南推荐进行分级,并开展了正式的共识达成过程。

结果

该指南包括34条关于急性护理中氧疗的适应证、处方、监测和停用的循证推荐。氧疗的主要适应证是低氧血症。在急性护理中,应避免低氧血症和高氧血症。高氧血症似乎也与死亡率增加有关,尤其是在高碳酸血症患者中。该指南提供了急性医学中推荐的目标氧饱和度,未区分诊断情况。氧饱和度的目标范围取决于通气状态和高碳酸血症风险。该指南概述了可用的氧气输送系统,并包括基于患者安全和舒适度进行选择的推荐。

结论

这是第一项关于急性护理中氧气使用的国家指南。它面向在急性院外和院内环境中使用氧气的医疗保健专业人员。该指南有效期为3年,至2024年6月30日。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验